Renata Limited

The company started its operations as a subsidiary of Pfizer Limited in 1972. For the next two decades it continued as a highly successful subsidiary of Pfizer Corporation. However, by the late 1990s the focus of Pfizer had shifted from formulations to research. In accordance with this transformation, Pfizer divested its interests in many countries, including Bangladesh. In 1993 Pfizer transferred the ownership of its Bangladesh operations to local shareholders, and the name of the company was changed to Renata Limited.

In a gesture of corporate charity, Pfizer donated 51% of its shares to SAJIDA Foundation. SAJIDA’s microfinance and micro-insurance programs support over 1 lac members and their families with a cumulative loan disbursement totaling to about BDT 575 Crores. SAJIDA’s health program covers over 10 lac beneficiaries by delivering services through 2 hospitals with 70 beds each, a panel doctors in SAJIDA’s micro finance branches as well as mobile health teams. The SAJIDA Foundation holds the majority ownership in Renata Limited - it grows with the growth of Renata Limited. To learn more please visit the foundation’s website: www.sajidafoundation.org

Renata Limited contributes about BDT 150 Crores annually to the National Exchequer.

Renata's Global Alliances are:
UNICEF (Oral Re-hydration Salts)
Novartis Vaccines (Rabipur, Vaxem HiB, and Agrippal)
BASF, Germany (Animal Nutrition Products)
InterVax, Canada (Meningococcal Vaccine)
Evans Vanodine, UK (Disinfectant)
Zinpro, USA (Metal Amino Acid Complexes)
Biomin Laboratories, Singapore (Mycotoxin Binders and Nutraceuticals)
Bomac Laboratories, New Zealand (Veterinary Products)

Renata Limited has International Presence in:
UK, Hong Kong, Philippines, Sri Lanka, Vietnam, Belize, Myanmar, Nepal, Cambodia, Kenya, Jordan, Guyana, Thailand, Afghanistan and Malaysia.